Clinical Trial

Biomarkers for Exercise

Recruiting
View on ClinicalTrials.gov →
Summary
The overarching objective is to examine the brain-based biological mechanistic pathway by which exercise exerts anxiolytic effects. The investigators will measure brain-derived markers of mitochondrial metabolism (acetyl-L-carnitine \[LAC\]) and inflammation (interleukin-6 \[IL-6\]) using innovative technology to isolate neuronal exosomes.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-01
Trial Details
NCT Number NCT07340281
Lead Sponsor NYU Langone Health
Conditions Anxiety Disorders
Enrollment 30 participants
Start Date 2026-03-06
Primary Completion 2027-08-01 (estimated)
Study Completion 2028-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-31